CapsoVision, Inc. (CV) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

CapsoVision, Inc. (CV) operates in the Healthcare sector, specifically the Medical - Equipment & Services industry, with a market capitalization near $336.8M, listed on NASDAQ, employing roughly 90 people, carrying a beta of -2.62 to the broader market. Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics Led by Kang-Huai Wang, public since 2001-09-03.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for CV as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →